Literature DB >> 27302626

B-type natriuretic peptide and plasma hemoglobin levels following transfusion of shorter-storage versus longer-storage red blood cells: Results from the TOTAL randomized trial.

Aggrey Dhabangi1, Brenda Ainomugisha2, Christine Cserti-Gazdewich3, Henry Ddungu4, Dorothy Kyeyune5, Ezra Musisi5, Robert Opoka6, Christopher P Stowell7, Walter H Dzik8.   

Abstract

BACKGROUND: Prior studies have suggested that transfusion of stored red blood cells (RBCs) with increased levels of cell-free hemoglobin might reduce the bioavailability of recipient nitric oxide (NO) and cause myocardial strain.
METHODS: Ugandan children (ages 6-60 months) with severe anemia and lactic acidosis were randomly assigned to receive RBCs stored 1-10 days versus 25-35 days. B-type natriuretic peptide (BNP), vital signs, renal function test results, and plasma hemoglobin were measured. Most children had either malaria or sickle cell disease and were thus at risk for reduced NO bioavailability.
RESULTS: Seventy patients received RBCs stored 1-10 days, and 77 received RBCs stored 25-35 days. The median (interquartile range) cell-free hemoglobin was nearly 3 times higher in longer-storage RBCs (26.4 [15.5-43.4] μmol/L) than in shorter-storage RBCs (10.8 [7.8-18.6] μmol/L), P < .0001. Median (interquartile range) BNP 2 hours posttransfusion was 156 (59-650) pg/mL (shorter storage) versus 158 (59-425) pg/mL (longer storage), P = .76. BNP values 22 hours posttransfusion were 110 (46-337) pg/mL (shorter storage) versus 96 (49-310) pg/mL (longer storage), P = .76. Changes in BNP within individuals from pretransfusion to 2 hours (or 22 hours) posttransfusion were not significantly different between the study groups. BNP change following transfusion did not correlate with the concentration of cell-free hemoglobin in the RBC supernatant. Blood pressure, blood urea nitrogen, creatinine, and change in plasma hemoglobin were not significantly different in the 2 groups.
CONCLUSION: In a randomized trial among children at risk for reduced NO bioavailability, we found that BNP, blood pressure, creatinine, and plasma hemoglobin were not higher in patients receiving RBCs stored for 25-35 versus 1-10 days.
Copyright © 2016 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27302626      PMCID: PMC4956578          DOI: 10.1016/j.ahj.2016.01.007

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  35 in total

1.  Pulmonary hypertension and NO in sickle cell.

Authors:  Mark T Gladwin; Robyn J Barst; Oswaldo L Castro; Victor R Gordeuk; Cheryl A Hillery; Gregory J Kato; Daniel B Kim-Shapiro; Roberto Machado; Claudia R Morris; Martin H Steinberg; Elliott P Vichinsky
Journal:  Blood       Date:  2010-08-05       Impact factor: 22.113

2.  Storage lesion: role of red blood cell breakdown.

Authors:  Daniel B Kim-Shapiro; Janet Lee; Mark T Gladwin
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

3.  Harmful effects of transfusion of older stored red blood cells: iron and inflammation.

Authors:  Eldad A Hod; Steven L Spitalnik
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

4.  Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion.

Authors:  Chenell Donadee; Nicolaas J H Raat; Tamir Kanias; Jesús Tejero; Janet S Lee; Eric E Kelley; Xuejun Zhao; Chen Liu; Hannah Reynolds; Ivan Azarov; Sheila Frizzell; E Michael Meyer; Albert D Donnenberg; Lirong Qu; Darrel Triulzi; Daniel B Kim-Shapiro; Mark T Gladwin
Journal:  Circulation       Date:  2011-07-11       Impact factor: 29.690

5.  The effects of red blood cell preparation method on in vitro markers of red blood cell aging and inflammatory response.

Authors:  Katherine Radwanski; Olivier Garraud; Fabrice Cognasse; Hind Hamzeh-Cognasse; Jean-Marc Payrat; Kyungyoon Min
Journal:  Transfusion       Date:  2013-03-05       Impact factor: 3.157

6.  Effects of red-cell storage duration on patients undergoing cardiac surgery.

Authors:  Marie E Steiner; Paul M Ness; Susan F Assmann; Darrell J Triulzi; Steven R Sloan; Meghan Delaney; Suzanne Granger; Elliott Bennett-Guerrero; Morris A Blajchman; Vincent Scavo; Jeffrey L Carson; Jerrold H Levy; Glenn Whitman; Pamela D'Andrea; Shelley Pulkrabek; Thomas L Ortel; Larissa Bornikova; Thomas Raife; Kathleen E Puca; Richard M Kaufman; Gregory A Nuttall; Pampee P Young; Samuel Youssef; Richard Engelman; Philip E Greilich; Ronald Miles; Cassandra D Josephson; Arthur Bracey; Rhonda Cooke; Jeffrey McCullough; Robert Hunsaker; Lynne Uhl; Janice G McFarland; Yara Park; Melissa M Cushing; Charles T Klodell; Ravindra Karanam; Pamela R Roberts; Cornelius Dyke; Eldad A Hod; Christopher P Stowell
Journal:  N Engl J Med       Date:  2015-04-09       Impact factor: 91.245

7.  Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria.

Authors:  Anita Hill; Russell P Rother; Xunde Wang; Sidney M Morris; Kerry Quinn-Senger; Richard Kelly; Stephen J Richards; Monica Bessler; Leonard Bell; Peter Hillmen; Mark T Gladwin
Journal:  Br J Haematol       Date:  2010-03-08       Impact factor: 6.998

Review 8.  Red blood cell hemolysis during processing.

Authors:  Samuel O Sowemimo-Coker
Journal:  Transfus Med Rev       Date:  2002-01

9.  N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.

Authors:  Roberto F Machado; Anastasia Anthi; Martin H Steinberg; Duane Bonds; Vandana Sachdev; Gregory J Kato; Angelo M Taveira-DaSilva; Samir K Ballas; William Blackwelder; Xiuli Xu; Lori Hunter; Bruce Barton; Myron Waclawiw; Oswaldo Castro; Mark T Gladwin
Journal:  JAMA       Date:  2006-07-19       Impact factor: 56.272

10.  Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations.

Authors:  Ersi Voskaridou; George Tsetsos; Antonios Tsoutsias; Evgenia Spyropoulou; Dimitrios Christoulas; Evangelos Terpos
Journal:  Haematologica       Date:  2007-06       Impact factor: 9.941

View more
  2 in total

1.  Safety of acoustic separation in plastic devices for extracorporeal blood processing.

Authors:  William J Savage; John R Burns; Jason Fiering
Journal:  Transfusion       Date:  2017-05-28       Impact factor: 3.157

2.  Evidence-based interventions implemented in low-and middle-income countries for sickle cell disease management: A systematic review of randomized controlled trials.

Authors:  Joyce Gyamfi; Temitope Ojo; Sabrina Epou; Amy Diawara; Lotanna Dike; Deborah Adenikinju; Scholastica Enechukwu; Dorice Vieira; Obiageli Nnodu; Gbenga Ogedegbe; Emmanuel Peprah
Journal:  PLoS One       Date:  2021-02-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.